Home208340 • KOSDAQ
add
PharmAbcine Inc
Previous close
₩2,915.00
Year range
₩2,895.00 - ₩3,435.00
Market cap
76.32B KRW
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 9.45B | — |
Operating expense | 3.31B | 28.43% |
Net income | 3.01B | 232.33% |
Net profit margin | 31.85 | — |
Earnings per share | — | — |
EBITDA | 2.61B | 202.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.79B | 14.02% |
Total assets | 63.93B | 20.15% |
Total liabilities | 13.70B | 63.48% |
Total equity | 50.23B | — |
Shares outstanding | 80.19M | — |
Price to book | 4.65 | — |
Return on assets | 9.98% | — |
Return on capital | 12.52% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 3.01B | 232.33% |
Cash from operations | 6.36B | — |
Cash from investing | -4.95B | — |
Cash from financing | -144.18M | — |
Net change in cash | 1.01B | — |
Free cash flow | 3.06B | 690.39% |
About
CEO
Founded
2008
Website
Employees
39
